| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 93 | 2016 | 21069 | 1.130 |
Why?
|
| Genes, BRCA1 | 12 | 2013 | 753 | 0.900 |
Why?
|
| DNA, Neoplasm | 14 | 2012 | 1739 | 0.570 |
Why?
|
| Receptors, Estrogen | 11 | 2009 | 2242 | 0.520 |
Why?
|
| NF-kappa B | 5 | 2013 | 2492 | 0.510 |
Why?
|
| Transcription Factor RelA | 1 | 2015 | 252 | 0.460 |
Why?
|
| Streptothricins | 1 | 2013 | 5 | 0.440 |
Why?
|
| Receptor, erbB-2 | 23 | 2016 | 2592 | 0.430 |
Why?
|
| Acetyltransferases | 1 | 2013 | 230 | 0.390 |
Why?
|
| Neoplasm Proteins | 12 | 2013 | 3592 | 0.390 |
Why?
|
| Genes, p53 | 11 | 1998 | 711 | 0.390 |
Why?
|
| Breast | 11 | 2015 | 1950 | 0.380 |
Why?
|
| Genes, BRCA2 | 3 | 2013 | 591 | 0.380 |
Why?
|
| Interferons | 1 | 2015 | 714 | 0.380 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 8 | 2015 | 921 | 0.310 |
Why?
|
| Gene Amplification | 10 | 2012 | 1088 | 0.300 |
Why?
|
| Tumor Suppressor Protein p53 | 12 | 2015 | 2945 | 0.290 |
Why?
|
| Transfection | 6 | 2013 | 5738 | 0.290 |
Why?
|
| DNA Damage | 7 | 2018 | 2462 | 0.290 |
Why?
|
| Specialties, Surgical | 1 | 2012 | 390 | 0.280 |
Why?
|
| Gene Expression Regulation, Neoplastic | 18 | 2015 | 8603 | 0.280 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2012 | 2877 | 0.260 |
Why?
|
| Ovarian Neoplasms | 14 | 2018 | 4904 | 0.260 |
Why?
|
| Ploidies | 4 | 1995 | 287 | 0.250 |
Why?
|
| Physician's Role | 1 | 2012 | 925 | 0.240 |
Why?
|
| Gene Expression | 11 | 2013 | 7581 | 0.240 |
Why?
|
| Genetic Testing | 5 | 2012 | 3594 | 0.240 |
Why?
|
| Drug Design | 1 | 2009 | 1039 | 0.230 |
Why?
|
| Loss of Heterozygosity | 4 | 2013 | 663 | 0.210 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2006 | 678 | 0.210 |
Why?
|
| Gene Expression Profiling | 11 | 2016 | 9525 | 0.200 |
Why?
|
| Apoptosis | 8 | 2016 | 9505 | 0.200 |
Why?
|
| Carcinoma in Situ | 4 | 2010 | 777 | 0.200 |
Why?
|
| BRCA1 Protein | 6 | 2006 | 1155 | 0.200 |
Why?
|
| Proto-Oncogenes | 4 | 1993 | 320 | 0.200 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2010 | 3796 | 0.180 |
Why?
|
| Cell Division | 9 | 2007 | 4466 | 0.180 |
Why?
|
| DNA-Activated Protein Kinase | 2 | 2013 | 111 | 0.180 |
Why?
|
| Proto-Oncogene Proteins | 9 | 2010 | 4520 | 0.180 |
Why?
|
| DNA Repair | 5 | 2016 | 2048 | 0.180 |
Why?
|
| Carcinoma, Bronchogenic | 3 | 1990 | 86 | 0.170 |
Why?
|
| Medical Oncology | 1 | 2012 | 2339 | 0.170 |
Why?
|
| RecQ Helicases | 2 | 2018 | 54 | 0.170 |
Why?
|
| Sirolimus | 1 | 2006 | 1541 | 0.160 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2009 | 3678 | 0.160 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 3 | 2012 | 904 | 0.160 |
Why?
|
| Estradiol | 4 | 2008 | 1947 | 0.160 |
Why?
|
| Genetic Counseling | 2 | 2002 | 634 | 0.150 |
Why?
|
| Nuclear Proteins | 6 | 2013 | 5782 | 0.150 |
Why?
|
| Neoplasm Staging | 21 | 2015 | 11196 | 0.150 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2012 | 122 | 0.150 |
Why?
|
| BRCA2 Protein | 6 | 2006 | 802 | 0.150 |
Why?
|
| Female | 102 | 2018 | 396141 | 0.140 |
Why?
|
| Neoplasms, Multiple Primary | 2 | 2015 | 589 | 0.140 |
Why?
|
| Platinum Compounds | 1 | 2018 | 94 | 0.140 |
Why?
|
| Cell Transformation, Neoplastic | 6 | 2012 | 2838 | 0.140 |
Why?
|
| Lymphatic Metastasis | 9 | 2011 | 2885 | 0.140 |
Why?
|
| Signal Transduction | 7 | 2013 | 23597 | 0.140 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2011 | 496 | 0.140 |
Why?
|
| Oncogene Proteins | 2 | 2011 | 710 | 0.130 |
Why?
|
| Immunohistochemistry | 14 | 2016 | 11030 | 0.130 |
Why?
|
| Phosphorylation | 6 | 2016 | 8279 | 0.130 |
Why?
|
| Mutation | 19 | 2013 | 30192 | 0.130 |
Why?
|
| Cell Cycle | 6 | 2004 | 2920 | 0.130 |
Why?
|
| Heterozygote | 6 | 2000 | 2796 | 0.130 |
Why?
|
| Transcriptional Activation | 2 | 2005 | 1743 | 0.130 |
Why?
|
| Humans | 129 | 2018 | 765926 | 0.130 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2015 | 69 | 0.130 |
Why?
|
| Neoplasm Invasiveness | 9 | 2015 | 3599 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 6 | 2005 | 5784 | 0.120 |
Why?
|
| Epithelial Cells | 9 | 2015 | 3684 | 0.120 |
Why?
|
| Cell Line, Tumor | 13 | 2015 | 17060 | 0.120 |
Why?
|
| Cell Line | 11 | 2015 | 15540 | 0.120 |
Why?
|
| Carcinoma, Small Cell | 3 | 1987 | 420 | 0.120 |
Why?
|
| Fallopian Tubes | 1 | 2015 | 179 | 0.120 |
Why?
|
| Carcinoma, Lobular | 3 | 2015 | 471 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 7473 | 0.120 |
Why?
|
| Carcinoma, Ductal, Breast | 4 | 2015 | 1086 | 0.120 |
Why?
|
| Stress, Physiological | 2 | 2012 | 1404 | 0.110 |
Why?
|
| Cyclin D1 | 4 | 2005 | 449 | 0.110 |
Why?
|
| Morpholines | 2 | 2016 | 577 | 0.110 |
Why?
|
| Ultraviolet Rays | 3 | 2014 | 1099 | 0.110 |
Why?
|
| Retinoblastoma Protein | 3 | 2015 | 666 | 0.110 |
Why?
|
| Hygromycin B | 1 | 2013 | 11 | 0.110 |
Why?
|
| Puromycin | 1 | 2013 | 41 | 0.110 |
Why?
|
| Neoplasm Metastasis | 6 | 2012 | 4882 | 0.110 |
Why?
|
| Genes, Dominant | 1 | 1996 | 855 | 0.110 |
Why?
|
| Autophagy | 2 | 2012 | 1350 | 0.110 |
Why?
|
| Mitotic Index | 1 | 1993 | 160 | 0.110 |
Why?
|
| Neomycin | 1 | 2013 | 94 | 0.110 |
Why?
|
| Tamoxifen | 4 | 2006 | 964 | 0.110 |
Why?
|
| Cinnamates | 1 | 2013 | 59 | 0.110 |
Why?
|
| Chromosomes, Human, X | 2 | 2006 | 319 | 0.110 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2015 | 659 | 0.110 |
Why?
|
| Drug Resistance, Neoplasm | 8 | 2016 | 5333 | 0.110 |
Why?
|
| Gene Silencing | 3 | 2010 | 1504 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2016 | 2057 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase 4 | 2 | 2015 | 561 | 0.100 |
Why?
|
| Pyrrolidinones | 1 | 2013 | 116 | 0.100 |
Why?
|
| Carcinoma | 5 | 2008 | 2311 | 0.100 |
Why?
|
| Cell Nucleolus | 2 | 2012 | 156 | 0.100 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1994 | 341 | 0.100 |
Why?
|
| Transcription Factors | 5 | 1999 | 12129 | 0.100 |
Why?
|
| Multiprotein Complexes | 2 | 2016 | 1107 | 0.100 |
Why?
|
| Aminopyridines | 1 | 2016 | 576 | 0.100 |
Why?
|
| RNA, Ribosomal | 1 | 2013 | 227 | 0.100 |
Why?
|
| Genomic Instability | 2 | 2016 | 716 | 0.100 |
Why?
|
| Antineoplastic Agents | 9 | 2018 | 13631 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 14 | 2001 | 6101 | 0.100 |
Why?
|
| Keratin-19 | 2 | 2009 | 33 | 0.100 |
Why?
|
| Allelic Imbalance | 1 | 2012 | 77 | 0.100 |
Why?
|
| Neoplastic Cells, Circulating | 2 | 2009 | 949 | 0.090 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2013 | 428 | 0.090 |
Why?
|
| Neoplasms, Hormone-Dependent | 3 | 2005 | 409 | 0.090 |
Why?
|
| Phosphoprotein Phosphatases | 2 | 2010 | 327 | 0.090 |
Why?
|
| Molecular Sequence Data | 18 | 2006 | 17596 | 0.090 |
Why?
|
| Mammary Glands, Animal | 1 | 2012 | 272 | 0.090 |
Why?
|
| Gene Expression Regulation | 3 | 2005 | 11895 | 0.090 |
Why?
|
| Lung Neoplasms | 9 | 1995 | 13446 | 0.090 |
Why?
|
| Cisplatin | 4 | 2013 | 1654 | 0.090 |
Why?
|
| Lymph Node Excision | 2 | 2011 | 1258 | 0.090 |
Why?
|
| Mutant Proteins | 1 | 2012 | 486 | 0.090 |
Why?
|
| Immunoglobulin A, Secretory | 2 | 1981 | 105 | 0.090 |
Why?
|
| DNA Helicases | 2 | 2013 | 852 | 0.090 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2012 | 194 | 0.090 |
Why?
|
| Genes, ras | 2 | 2007 | 656 | 0.090 |
Why?
|
| Membrane Proteins | 3 | 2012 | 7847 | 0.080 |
Why?
|
| Genes, erbB-2 | 4 | 2007 | 160 | 0.080 |
Why?
|
| Genes, Neoplasm | 1 | 2012 | 369 | 0.080 |
Why?
|
| Phyllodes Tumor | 2 | 2006 | 54 | 0.080 |
Why?
|
| False Positive Reactions | 2 | 2009 | 956 | 0.080 |
Why?
|
| Anoikis | 1 | 2009 | 49 | 0.080 |
Why?
|
| Breast Diseases | 2 | 1992 | 436 | 0.080 |
Why?
|
| Methylnitrosourea | 2 | 2007 | 30 | 0.080 |
Why?
|
| Hyperplasia | 1 | 2012 | 1142 | 0.080 |
Why?
|
| Down-Regulation | 2 | 2015 | 2925 | 0.080 |
Why?
|
| Carcinoma, Ductal | 1 | 2009 | 97 | 0.080 |
Why?
|
| Neoplasms, Basal Cell | 2 | 2006 | 30 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1990 | 412 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2016 | 2897 | 0.080 |
Why?
|
| Genes, Lethal | 1 | 2009 | 224 | 0.080 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2010 | 268 | 0.080 |
Why?
|
| Transcription, Genetic | 5 | 2015 | 7599 | 0.080 |
Why?
|
| Genomics | 1 | 2004 | 5925 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2012 | 2470 | 0.070 |
Why?
|
| Mammography | 5 | 2009 | 2424 | 0.070 |
Why?
|
| Chromosome Aberrations | 3 | 2013 | 1775 | 0.070 |
Why?
|
| Prognosis | 16 | 2015 | 29890 | 0.070 |
Why?
|
| Fibroma | 1 | 2009 | 197 | 0.070 |
Why?
|
| Ki-67 Antigen | 3 | 2016 | 628 | 0.070 |
Why?
|
| Epithelium | 8 | 1998 | 1603 | 0.070 |
Why?
|
| Mice, SCID | 4 | 2016 | 2626 | 0.070 |
Why?
|
| Base Sequence | 17 | 2009 | 12405 | 0.070 |
Why?
|
| Neuregulin-1 | 2 | 2007 | 140 | 0.070 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2008 | 186 | 0.070 |
Why?
|
| RNA, Messenger | 12 | 2012 | 12768 | 0.070 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2011 | 730 | 0.070 |
Why?
|
| Interferon-gamma | 1 | 2015 | 3158 | 0.070 |
Why?
|
| Estrogens | 3 | 2005 | 1528 | 0.070 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2009 | 715 | 0.070 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 8 | 2010 | 11858 | 0.070 |
Why?
|
| Phthalazines | 1 | 2009 | 397 | 0.070 |
Why?
|
| DNA | 5 | 2012 | 7193 | 0.070 |
Why?
|
| Immunoglobulin A | 2 | 1981 | 992 | 0.070 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2006 | 203 | 0.070 |
Why?
|
| Fibroadenoma | 1 | 2006 | 40 | 0.070 |
Why?
|
| Intercellular Junctions | 1 | 1987 | 198 | 0.070 |
Why?
|
| Animals | 24 | 2016 | 168735 | 0.060 |
Why?
|
| Reference Values | 3 | 2009 | 4909 | 0.060 |
Why?
|
| Cluster Analysis | 4 | 2006 | 2717 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 8 | 2009 | 9239 | 0.060 |
Why?
|
| Neoplasms | 3 | 2012 | 22340 | 0.060 |
Why?
|
| Telomere | 1 | 2012 | 941 | 0.060 |
Why?
|
| Flavonoids | 3 | 2009 | 445 | 0.060 |
Why?
|
| Cell Proliferation | 4 | 2015 | 10426 | 0.060 |
Why?
|
| Bronchial Fistula | 1 | 1986 | 82 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 17 | 3 | 2006 | 417 | 0.060 |
Why?
|
| Bronchi | 4 | 1992 | 843 | 0.060 |
Why?
|
| Pancreatic Fistula | 1 | 1986 | 149 | 0.060 |
Why?
|
| Germ-Line Mutation | 3 | 2013 | 1885 | 0.060 |
Why?
|
| DNA-Binding Proteins | 5 | 2014 | 9600 | 0.060 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2005 | 133 | 0.060 |
Why?
|
| I-kappa B Proteins | 1 | 2005 | 210 | 0.060 |
Why?
|
| Mastectomy, Segmental | 2 | 2008 | 964 | 0.060 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2006 | 1535 | 0.060 |
Why?
|
| Receptors, Progesterone | 1 | 2009 | 1152 | 0.060 |
Why?
|
| Annexin A5 | 1 | 2004 | 102 | 0.060 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2016 | 3604 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2010 | 2455 | 0.060 |
Why?
|
| Disease Progression | 4 | 2010 | 13614 | 0.050 |
Why?
|
| Chemotherapy, Adjuvant | 3 | 2007 | 3542 | 0.050 |
Why?
|
| Cyclins | 2 | 1996 | 598 | 0.050 |
Why?
|
| DNA Topoisomerases, Type II | 2 | 2001 | 122 | 0.050 |
Why?
|
| Sensitivity and Specificity | 5 | 2012 | 14643 | 0.050 |
Why?
|
| Middle Aged | 31 | 2015 | 223016 | 0.050 |
Why?
|
| Fibrinogen | 1 | 2006 | 895 | 0.050 |
Why?
|
| Cells, Cultured | 7 | 2010 | 18962 | 0.050 |
Why?
|
| Mice | 15 | 2016 | 81782 | 0.050 |
Why?
|
| Biopsy | 3 | 2009 | 6766 | 0.050 |
Why?
|
| Mice, Inbred NOD | 3 | 2015 | 1837 | 0.050 |
Why?
|
| X Chromosome Inactivation | 1 | 2005 | 229 | 0.050 |
Why?
|
| Cell Survival | 3 | 2009 | 5745 | 0.050 |
Why?
|
| Etoposide | 3 | 2001 | 636 | 0.050 |
Why?
|
| Blotting, Western | 4 | 2012 | 5019 | 0.050 |
Why?
|
| Axilla | 4 | 2011 | 615 | 0.050 |
Why?
|
| Chromatin | 2 | 2013 | 2979 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2008 | 1852 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 1995 | 5379 | 0.040 |
Why?
|
| Neoplasm Transplantation | 4 | 2016 | 2008 | 0.040 |
Why?
|
| Lymph Nodes | 3 | 2000 | 3447 | 0.040 |
Why?
|
| Spouses | 1 | 2003 | 286 | 0.040 |
Why?
|
| Proteome | 2 | 2012 | 1896 | 0.040 |
Why?
|
| Enzyme Activation | 4 | 2013 | 3583 | 0.040 |
Why?
|
| Aged | 22 | 2015 | 171163 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 2011 | 9373 | 0.040 |
Why?
|
| Mice, Nude | 4 | 2013 | 3608 | 0.040 |
Why?
|
| Southeastern United States | 1 | 2000 | 94 | 0.040 |
Why?
|
| Chromosome Deletion | 4 | 1996 | 1384 | 0.040 |
Why?
|
| Decision Trees | 2 | 2000 | 509 | 0.040 |
Why?
|
| Carrier Proteins | 4 | 2016 | 4909 | 0.040 |
Why?
|
| Antigens, Nuclear | 2 | 2012 | 182 | 0.040 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2003 | 566 | 0.040 |
Why?
|
| Pattern Recognition, Automated | 1 | 2006 | 979 | 0.040 |
Why?
|
| Amino Acid Sequence | 5 | 2006 | 13398 | 0.040 |
Why?
|
| Adult | 24 | 2015 | 223088 | 0.040 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 1998 | 1621 | 0.040 |
Why?
|
| Adenocarcinoma | 6 | 2009 | 6360 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 2 | 1996 | 1060 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2006 | 1611 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2015 | 3788 | 0.040 |
Why?
|
| Transplantation, Heterologous | 6 | 2011 | 2390 | 0.040 |
Why?
|
| Predictive Value of Tests | 6 | 2008 | 15401 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2003 | 18074 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2003 | 4055 | 0.040 |
Why?
|
| Enzyme Inhibitors | 3 | 2000 | 3716 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2006 | 2194 | 0.040 |
Why?
|
| Diagnosis, Differential | 3 | 2009 | 12973 | 0.040 |
Why?
|
| Macrophages | 1 | 1993 | 5772 | 0.040 |
Why?
|
| Piperazines | 1 | 2009 | 2546 | 0.040 |
Why?
|
| Proteomics | 1 | 2012 | 3906 | 0.040 |
Why?
|
| Neoplasms, Second Primary | 1 | 2006 | 1056 | 0.040 |
Why?
|
| Ligands | 1 | 2005 | 3272 | 0.040 |
Why?
|
| Piperidines | 2 | 2009 | 1664 | 0.040 |
Why?
|
| Epidermal Growth Factor | 2 | 2001 | 697 | 0.040 |
Why?
|
| Topoisomerase II Inhibitors | 1 | 1998 | 94 | 0.040 |
Why?
|
| DNA Primers | 5 | 2009 | 2824 | 0.040 |
Why?
|
| Topoisomerase I Inhibitors | 1 | 1998 | 70 | 0.040 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2000 | 427 | 0.040 |
Why?
|
| Models, Biological | 4 | 2012 | 9443 | 0.040 |
Why?
|
| Alleles | 4 | 2006 | 6891 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 2 | 1995 | 1996 | 0.030 |
Why?
|
| Exons | 3 | 2010 | 2393 | 0.030 |
Why?
|
| Follow-Up Studies | 7 | 2015 | 39228 | 0.030 |
Why?
|
| Flow Cytometry | 4 | 2014 | 5880 | 0.030 |
Why?
|
| Rats, Inbred WF | 2 | 2007 | 139 | 0.030 |
Why?
|
| Receptor, IGF Type 2 | 1 | 1996 | 35 | 0.030 |
Why?
|
| Cell Cycle Proteins | 2 | 2016 | 3431 | 0.030 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 2 | 1994 | 220 | 0.030 |
Why?
|
| Estrogen Antagonists | 1 | 1997 | 151 | 0.030 |
Why?
|
| Vinblastine | 2 | 2009 | 483 | 0.030 |
Why?
|
| Lovastatin | 1 | 1996 | 114 | 0.030 |
Why?
|
| Colorectal Neoplasms | 2 | 2010 | 6958 | 0.030 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 1999 | 249 | 0.030 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2016 | 83 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2007 | 2895 | 0.030 |
Why?
|
| DNA, Antisense | 1 | 1995 | 44 | 0.030 |
Why?
|
| Aged, 80 and over | 8 | 2015 | 59496 | 0.030 |
Why?
|
| Blotting, Northern | 5 | 1996 | 1546 | 0.030 |
Why?
|
| Insulin | 1 | 1990 | 6603 | 0.030 |
Why?
|
| Combined Modality Therapy | 6 | 2007 | 8522 | 0.030 |
Why?
|
| Transglutaminases | 1 | 1996 | 200 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2005 | 2270 | 0.030 |
Why?
|
| Ovary | 2 | 1996 | 961 | 0.030 |
Why?
|
| Genome, Human | 3 | 2013 | 4443 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2016 | 9065 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2005 | 2031 | 0.030 |
Why?
|
| Camptothecin | 1 | 1998 | 598 | 0.030 |
Why?
|
| Genetic Markers | 5 | 2004 | 2603 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2012 | 3070 | 0.030 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 1998 | 615 | 0.030 |
Why?
|
| Carcinogens | 2 | 2005 | 451 | 0.030 |
Why?
|
| Pyrimidine Dimers | 1 | 2014 | 19 | 0.030 |
Why?
|
| DNA Methylation | 2 | 2006 | 4424 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2006 | 5126 | 0.030 |
Why?
|
| Genital Neoplasms, Female | 1 | 1999 | 534 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2016 | 731 | 0.030 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1996 | 462 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 1993 | 6202 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1995 | 780 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 5 | 2010 | 6058 | 0.030 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 1994 | 202 | 0.030 |
Why?
|
| GTP Phosphohydrolases | 1 | 1996 | 523 | 0.030 |
Why?
|
| Cell Growth Processes | 1 | 2013 | 380 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2009 | 6542 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2000 | 1489 | 0.030 |
Why?
|
| Metallothionein | 1 | 1992 | 62 | 0.030 |
Why?
|
| RNA Interference | 2 | 2011 | 2829 | 0.030 |
Why?
|
| Remission Induction | 2 | 2016 | 2413 | 0.030 |
Why?
|
| Point Mutation | 2 | 1996 | 1590 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1991 | 1305 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 1996 | 944 | 0.020 |
Why?
|
| Quality-Adjusted Life Years | 1 | 1999 | 1740 | 0.020 |
Why?
|
| Trachea | 2 | 1989 | 1091 | 0.020 |
Why?
|
| DNA, Satellite | 1 | 1992 | 67 | 0.020 |
Why?
|
| Counseling | 1 | 2000 | 1551 | 0.020 |
Why?
|
| S Phase | 1 | 2013 | 423 | 0.020 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2012 | 151 | 0.020 |
Why?
|
| Calcinosis | 2 | 1992 | 1475 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 1994 | 4163 | 0.020 |
Why?
|
| Reproducibility of Results | 5 | 2007 | 20133 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1994 | 457 | 0.020 |
Why?
|
| Doxorubicin | 4 | 2007 | 2226 | 0.020 |
Why?
|
| Neuroectodermal Tumors, Primitive, Peripheral | 1 | 1992 | 43 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2002 | 2331 | 0.020 |
Why?
|
| Polyomavirus | 1 | 2012 | 236 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2006 | 2661 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2012 | 16039 | 0.020 |
Why?
|
| Phenotype | 1 | 2009 | 16714 | 0.020 |
Why?
|
| Staining and Labeling | 2 | 1995 | 1072 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2000 | 2020 | 0.020 |
Why?
|
| DNA Mutational Analysis | 2 | 2003 | 4111 | 0.020 |
Why?
|
| Nerve Block | 1 | 1998 | 715 | 0.020 |
Why?
|
| North Carolina | 2 | 2002 | 329 | 0.020 |
Why?
|
| Mastectomy | 3 | 2008 | 1848 | 0.020 |
Why?
|
| Drug Synergism | 2 | 2007 | 1751 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 2011 | 386 | 0.020 |
Why?
|
| Cathepsins | 1 | 2011 | 242 | 0.020 |
Why?
|
| Cyclophosphamide | 3 | 2007 | 2232 | 0.020 |
Why?
|
| Culture Media | 1 | 1992 | 889 | 0.020 |
Why?
|
| RNA, Neoplasm | 4 | 1995 | 745 | 0.020 |
Why?
|
| Phagosomes | 1 | 2011 | 193 | 0.020 |
Why?
|
| Risk | 3 | 2008 | 9599 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2001 | 2662 | 0.020 |
Why?
|
| 3T3 Cells | 2 | 2002 | 1079 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2000 | 1979 | 0.020 |
Why?
|
| G1 Phase | 3 | 1996 | 403 | 0.020 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 1997 | 1225 | 0.020 |
Why?
|
| Ribosomes | 1 | 2013 | 494 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2005 | 14450 | 0.020 |
Why?
|
| Immunoblotting | 2 | 2009 | 1643 | 0.020 |
Why?
|
| Ribonucleoproteins | 1 | 2012 | 359 | 0.020 |
Why?
|
| Decision Making | 1 | 2003 | 3955 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1997 | 1936 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 1999 | 2004 | 0.020 |
Why?
|
| Xeroradiography | 1 | 1988 | 6 | 0.020 |
Why?
|
| Postmenopause | 2 | 2008 | 2517 | 0.020 |
Why?
|
| Immunomagnetic Separation | 1 | 2009 | 78 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1995 | 1363 | 0.020 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 1993 | 698 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2001 | 3477 | 0.020 |
Why?
|
| High Mobility Group Proteins | 1 | 2009 | 179 | 0.020 |
Why?
|
| Zinc | 1 | 1992 | 675 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 1992 | 790 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2010 | 451 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2013 | 1130 | 0.020 |
Why?
|
| Retrospective Studies | 8 | 2012 | 81537 | 0.020 |
Why?
|
| Bronchoscopy | 2 | 1986 | 913 | 0.020 |
Why?
|
| Exodeoxyribonucleases | 1 | 2009 | 191 | 0.020 |
Why?
|
| Leukemia Virus, Murine | 1 | 1988 | 95 | 0.020 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2009 | 169 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 613 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 1998 | 2627 | 0.020 |
Why?
|
| Biopsy, Needle | 2 | 1992 | 1613 | 0.020 |
Why?
|
| beta 2-Microglobulin | 1 | 2008 | 330 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2016 | 2444 | 0.020 |
Why?
|
| Formaldehyde | 1 | 1989 | 354 | 0.020 |
Why?
|
| Quinazolines | 1 | 2013 | 1366 | 0.020 |
Why?
|
| Rats | 4 | 2007 | 23708 | 0.020 |
Why?
|
| Desmosomes | 1 | 1987 | 72 | 0.020 |
Why?
|
| Treatment Failure | 1 | 1993 | 2653 | 0.020 |
Why?
|
| Cohort Studies | 4 | 2010 | 41680 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2011 | 2476 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 3801 | 0.020 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2007 | 255 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2008 | 12529 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1987 | 822 | 0.020 |
Why?
|
| Gene Deletion | 1 | 1994 | 2667 | 0.020 |
Why?
|
| Time Factors | 5 | 2013 | 40097 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 1938 | 0.020 |
Why?
|
| Treatment Outcome | 5 | 2013 | 65194 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 6306 | 0.020 |
Why?
|
| Histones | 1 | 1996 | 2590 | 0.020 |
Why?
|
| I-kappa B Kinase | 1 | 2007 | 249 | 0.020 |
Why?
|
| Lysosomes | 1 | 2011 | 932 | 0.020 |
Why?
|
| Uniparental Disomy | 1 | 2006 | 46 | 0.020 |
Why?
|
| Amylases | 1 | 1986 | 171 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 1998 | 4423 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2010 | 1202 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 36547 | 0.020 |
Why?
|
| Genes, X-Linked | 1 | 2006 | 129 | 0.020 |
Why?
|
| Protein Binding | 2 | 2012 | 9296 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2006 | 285 | 0.020 |
Why?
|
| Chromosome Mapping | 3 | 2004 | 4617 | 0.020 |
Why?
|
| Dexamethasone | 1 | 1992 | 1962 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2012 | 1308 | 0.010 |
Why?
|
| Protein Array Analysis | 1 | 2006 | 398 | 0.010 |
Why?
|
| Cell Nucleus | 2 | 2006 | 2864 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4563 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 1 | 1999 | 2924 | 0.010 |
Why?
|
| Esophageal Neoplasms | 1 | 1995 | 1659 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 2823 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 1996 | 373 | 0.010 |
Why?
|
| Prospective Studies | 4 | 2015 | 54807 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 1992 | 1995 | 0.010 |
Why?
|
| Body Fluids | 1 | 1986 | 320 | 0.010 |
Why?
|
| Automation | 1 | 2006 | 585 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1988 | 1346 | 0.010 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 2045 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 1992 | 1264 | 0.010 |
Why?
|
| Survival Rate | 2 | 1995 | 12822 | 0.010 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1992 | 1163 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 1992 | 3400 | 0.010 |
Why?
|
| Restriction Mapping | 2 | 1995 | 848 | 0.010 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1986 | 520 | 0.010 |
Why?
|
| Smoking | 3 | 1995 | 9082 | 0.010 |
Why?
|
| Pleural Effusion | 1 | 1986 | 344 | 0.010 |
Why?
|
| Endometrial Neoplasms | 1 | 1992 | 1378 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2004 | 386 | 0.010 |
Why?
|
| RNA, Untranslated | 1 | 2006 | 454 | 0.010 |
Why?
|
| Heterochromatin | 1 | 2005 | 294 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2004 | 340 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1992 | 4161 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1985 | 2543 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2012 | 6838 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 3749 | 0.010 |
Why?
|
| Surgical Procedures, Operative | 1 | 1993 | 1930 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2013 | 18292 | 0.010 |
Why?
|
| Biological Transport | 1 | 2006 | 2081 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1998 | 10380 | 0.010 |
Why?
|
| CpG Islands | 1 | 2006 | 1207 | 0.010 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2001 | 109 | 0.010 |
Why?
|
| Survival Analysis | 1 | 1993 | 10086 | 0.010 |
Why?
|
| Sarcoma | 1 | 1992 | 1799 | 0.010 |
Why?
|
| Oligonucleotide Probes | 2 | 1991 | 416 | 0.010 |
Why?
|
| Species Specificity | 1 | 2005 | 2406 | 0.010 |
Why?
|
| Risk Factors | 4 | 2008 | 74850 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2006 | 1332 | 0.010 |
Why?
|
| Risk Assessment | 2 | 1999 | 24275 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 2000 | 186 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 2000 | 147 | 0.010 |
Why?
|
| Upstream Stimulatory Factors | 1 | 1999 | 17 | 0.010 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2000 | 58 | 0.010 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 1 | 1999 | 137 | 0.010 |
Why?
|
| Butadienes | 1 | 2000 | 107 | 0.010 |
Why?
|
| Transcription Factor DP1 | 1 | 1999 | 135 | 0.010 |
Why?
|
| Chromones | 1 | 2000 | 148 | 0.010 |
Why?
|
| Robotics | 1 | 2006 | 807 | 0.010 |
Why?
|
| Incidence | 2 | 2015 | 21513 | 0.010 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 1999 | 96 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2012 | 9541 | 0.010 |
Why?
|
| Family | 2 | 2002 | 3208 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 1999 | 325 | 0.010 |
Why?
|
| E2F Transcription Factors | 1 | 1999 | 269 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 1988 | 2206 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2000 | 473 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2007 | 6209 | 0.010 |
Why?
|
| Isoquinolines | 1 | 2000 | 350 | 0.010 |
Why?
|
| Linear Models | 1 | 2008 | 5873 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2000 | 478 | 0.010 |
Why?
|
| Cell Movement | 1 | 2010 | 5190 | 0.010 |
Why?
|
| Androstadienes | 1 | 2000 | 347 | 0.010 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 1998 | 108 | 0.010 |
Why?
|
| Dimerization | 1 | 1999 | 880 | 0.010 |
Why?
|
| Respiratory System | 1 | 1981 | 562 | 0.010 |
Why?
|
| Kinetics | 2 | 1995 | 6273 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2007 | 2248 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2000 | 484 | 0.010 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2001 | 614 | 0.010 |
Why?
|
| Recurrence | 1 | 2010 | 8492 | 0.010 |
Why?
|
| Receptor, TIE-2 | 1 | 1998 | 183 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2007 | 3447 | 0.010 |
Why?
|
| Research Subjects | 1 | 1999 | 248 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1988 | 5500 | 0.010 |
Why?
|
| Male | 10 | 2007 | 363815 | 0.010 |
Why?
|
| Immediate-Early Proteins | 1 | 1999 | 444 | 0.010 |
Why?
|
| Age Factors | 1 | 2013 | 18382 | 0.010 |
Why?
|
| Viral Envelope Proteins | 1 | 1999 | 639 | 0.010 |
Why?
|
| Thionucleotides | 1 | 1995 | 107 | 0.010 |
Why?
|
| Epitopes | 2 | 1992 | 2523 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2005 | 1894 | 0.010 |
Why?
|
| Protamine Kinase | 1 | 1994 | 12 | 0.010 |
Why?
|
| Actuarial Analysis | 1 | 1995 | 370 | 0.010 |
Why?
|
| Registries | 2 | 2002 | 8346 | 0.010 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 1995 | 219 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1995 | 363 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2000 | 1239 | 0.010 |
Why?
|
| Mitosis | 1 | 2000 | 1175 | 0.010 |
Why?
|
| Nitriles | 1 | 2000 | 981 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2007 | 5987 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2013 | 12803 | 0.010 |
Why?
|
| Educational Status | 1 | 2002 | 2510 | 0.010 |
Why?
|
| Poly A | 1 | 1994 | 180 | 0.010 |
Why?
|
| Fluorouracil | 2 | 1990 | 1648 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2007 | 12059 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2008 | 5088 | 0.010 |
Why?
|
| Breast Neoplasms, Male | 1 | 1995 | 213 | 0.010 |
Why?
|
| Kidney | 1 | 2009 | 7073 | 0.010 |
Why?
|
| Esophagogastric Junction | 1 | 1995 | 350 | 0.010 |
Why?
|
| DNA Replication | 1 | 2000 | 1428 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1996 | 1885 | 0.010 |
Why?
|
| Tissue Embedding | 1 | 1992 | 43 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 1998 | 1777 | 0.010 |
Why?
|
| Paraffin Embedding | 1 | 1993 | 302 | 0.010 |
Why?
|
| Endometrium | 1 | 1995 | 404 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 1995 | 561 | 0.010 |
Why?
|
| Logistic Models | 1 | 2007 | 13273 | 0.010 |
Why?
|
| Neuraminidase | 1 | 1992 | 190 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1996 | 1494 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2007 | 4044 | 0.010 |
Why?
|
| Health Surveys | 1 | 2002 | 4058 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2005 | 3816 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 1998 | 1407 | 0.010 |
Why?
|
| Freezing | 1 | 1992 | 310 | 0.010 |
Why?
|
| Tissue Fixation | 1 | 1992 | 245 | 0.010 |
Why?
|
| Drug Administration Schedule | 2 | 1990 | 4851 | 0.010 |
Why?
|
| Binding Sites | 1 | 1999 | 5999 | 0.010 |
Why?
|
| Anesthesia, General | 1 | 1998 | 1182 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1994 | 1159 | 0.010 |
Why?
|
| Half-Life | 1 | 1992 | 645 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1991 | 772 | 0.010 |
Why?
|
| Genotype | 1 | 2005 | 13026 | 0.010 |
Why?
|
| Cytological Techniques | 1 | 1992 | 217 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2000 | 6321 | 0.010 |
Why?
|
| Codon | 1 | 1992 | 599 | 0.010 |
Why?
|
| Carbohydrates | 1 | 1992 | 387 | 0.010 |
Why?
|
| Neoplasm, Residual | 1 | 1995 | 1009 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2006 | 14745 | 0.010 |
Why?
|
| Trans-Activators | 1 | 1999 | 2848 | 0.010 |
Why?
|
| Mammals | 1 | 1995 | 1126 | 0.010 |
Why?
|
| Cell Separation | 1 | 1995 | 1718 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 1724 | 0.010 |
Why?
|
| Leukopenia | 1 | 1990 | 213 | 0.010 |
Why?
|
| Methionine | 1 | 1992 | 569 | 0.010 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 1992 | 335 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1994 | 1167 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1992 | 1695 | 0.000 |
Why?
|
| Prevalence | 1 | 2006 | 15828 | 0.000 |
Why?
|
| ROC Curve | 1 | 1997 | 3612 | 0.000 |
Why?
|
| Drug Evaluation | 1 | 1990 | 642 | 0.000 |
Why?
|
| Extracellular Matrix | 1 | 1996 | 1727 | 0.000 |
Why?
|
| Gene Rearrangement | 1 | 1994 | 1143 | 0.000 |
Why?
|
| Tretinoin | 1 | 1992 | 524 | 0.000 |
Why?
|
| Methylnitronitrosoguanidine | 1 | 1988 | 18 | 0.000 |
Why?
|
| Endopeptidases | 1 | 1992 | 760 | 0.000 |
Why?
|
| Sequence Analysis, DNA | 1 | 1999 | 4780 | 0.000 |
Why?
|
| 4-Nitroquinoline-1-oxide | 1 | 1988 | 17 | 0.000 |
Why?
|
| Friend murine leukemia virus | 1 | 1988 | 37 | 0.000 |
Why?
|
| Leukemia, Radiation-Induced | 1 | 1988 | 36 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1996 | 2601 | 0.000 |
Why?
|
| Lung | 1 | 1987 | 10046 | 0.000 |
Why?
|
| Inflammation | 1 | 1987 | 10843 | 0.000 |
Why?
|
| Pain, Postoperative | 1 | 1998 | 1767 | 0.000 |
Why?
|
| United States | 1 | 2015 | 72909 | 0.000 |
Why?
|
| Colony-Forming Units Assay | 1 | 1987 | 351 | 0.000 |
Why?
|
| Mucous Membrane | 1 | 1990 | 658 | 0.000 |
Why?
|
| Rats, Inbred F344 | 1 | 1988 | 820 | 0.000 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1989 | 938 | 0.000 |
Why?
|
| Pilot Projects | 1 | 2000 | 8724 | 0.000 |
Why?
|
| Hot Temperature | 1 | 1992 | 1433 | 0.000 |
Why?
|
| Algorithms | 1 | 2006 | 14064 | 0.000 |
Why?
|
| Thymus Neoplasms | 1 | 1988 | 270 | 0.000 |
Why?
|
| Vincristine | 1 | 1987 | 1037 | 0.000 |
Why?
|
| Blood | 1 | 1987 | 597 | 0.000 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1995 | 2674 | 0.000 |
Why?
|
| Cilia | 1 | 1989 | 499 | 0.000 |
Why?
|
| Length of Stay | 1 | 1998 | 6486 | 0.000 |
Why?
|
| RNA | 1 | 1994 | 2716 | 0.000 |
Why?
|
| Methotrexate | 1 | 1990 | 1719 | 0.000 |
Why?
|
| Antigens, Viral | 1 | 1988 | 995 | 0.000 |
Why?
|
| Rabbits | 1 | 1989 | 4729 | 0.000 |
Why?
|
| Cell Differentiation | 2 | 1992 | 11639 | 0.000 |
Why?
|
| Mass Screening | 1 | 1998 | 5449 | 0.000 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1988 | 1800 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 2001 | 26282 | 0.000 |
Why?
|
| Adolescent | 2 | 1992 | 88811 | 0.000 |
Why?
|
| Lymphoma | 1 | 1988 | 1896 | 0.000 |
Why?
|
| Protein Kinase Inhibitors | 1 | 1994 | 5691 | 0.000 |
Why?
|
| Radiography | 1 | 1989 | 6941 | 0.000 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 1979 | 209 | 0.000 |
Why?
|
| Chromosomes | 1 | 1979 | 578 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1988 | 10727 | 0.000 |
Why?
|
| Isoenzymes | 1 | 1979 | 1688 | 0.000 |
Why?
|
| Calcium | 1 | 1987 | 5769 | 0.000 |
Why?
|
| Receptors, Cell Surface | 1 | 1979 | 2814 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 1988 | 22327 | 0.000 |
Why?
|